Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04760717 · ClinicalTrials.gov registry record · Phase 2
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
A Phase 2 study of Ischemic Stroke and Intracerebral Hemorrhage, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 5
- Study locations
NCT04760717 is a Phase 2 study of Ischemic Stroke and Intracerebral Hemorrhage that is actively recruiting participants, run by Yale University. The registered enrollment target is 200 participants, below the 1,461-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT04760717, a Phase 2 study of Ischemic Stroke and Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering blood pressure in stroke survivors.
Conditions Studied
Interventions
- DRUG Spironolactone Pill
Study Locations (5)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Temple University Hospital - Philadelphia
Connecticut
- Yale New Haven Hospital - New Haven
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Texas
- University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-03-19 |
| Est. Completion | 2025-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04760717
The ClinicalTrials.gov registry entry for NCT04760717 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,461-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (86% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Spironolactone Pill is the first listed.
NCT04760717 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Pennsylvania, Connecticut, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04760717 about?
NCT04760717 is a clinical study titled "Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke". The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering blood pressure in stroke survivors.
What is the current status of trial NCT04760717?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2021-03-19. Estimated completion is 2025-12.
What conditions does trial NCT04760717 study?
This clinical trial studies the following conditions: Ischemic Stroke, Intracerebral Hemorrhage, Spironolactone.
What interventions are being tested in trial NCT04760717?
The interventions under investigation include: Spironolactone Pill (DRUG).
Who is sponsoring clinical trial NCT04760717?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04760717 being conducted?
This trial has 5 study locations across Connecticut, North Carolina, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Strategy for Improving Stroke Treatment Response
RECRUITING · Phase 2
-
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
RECRUITING · Phase 2
-
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
RECRUITING · Phase 2
-
Dietary Nitrate Supplements and Ischemic Stroke Recovery
COMPLETED · Phase 2
-
Mayo Acute Stroke Trial for Enhancing Recovery
COMPLETED · Phase 2
-
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.